Richard A Rudick. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adjuvants, Immunologic/administration & dosageFemaleHumansInterferon beta-1aInterferon-beta/administration & dosageInterleukin-17/bloodMaleMultiple Sclerosis, Relapsing-Remitting/bloodMultiple Sclerosis, Relapsing-Remitting/drug therapy
Substances: See more » Adjuvants, ImmunologicIL17F protein, humanInterleukin-17Interferon-betaInterferon beta-1a
Year: 2012 PMID: 22573625 DOI: 10.1212/WNL.0b013e318259e13a
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910